Cost-effectiveness of nonavalent vs bivalent HPV vaccine in Polish setting
Michał Jakubczyk, Joanna Bieganska, Katarzyna Kowalczuk, Rafal Jaworski et autres
OBJECTIVES: Human papillomavirus (HPV) is a prevalent sexually transmitted infection with significant implications for public health. In Poland, a nationwide vaccination program offers a choice between the 9-valent (9v) and 2-valent (2v) HPV vaccines. We aimed to assess the cost-effectiveness of the …
pl, us (code pays fourni par la source)